Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record and site navigation with an access-denied screen, which prevents viewing the trial details.
    Difference
    19%
    Check dated 2026-09-21T20:55:40.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, indicating a backend/template update. This change reflects a version bump rather than modifications to study details or data.
    Difference
    0.1%
    Check dated 2026-08-31T17:43:46.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.5 on the page. This indicates a minor maintenance update to the study page's content or metadata.
    Difference
    0.1%
    Check dated 2026-08-10T12:57:17.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The study record revision identifier was updated from v3.6.3 to v3.6.4, indicating a small backend/content management update.
    Difference
    0.1%
    Check dated 2026-07-27T05:56:23.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    New update dates 2026-07-15, 2026-07-13, and 2026-07 were added. Older update dates 2025-07-02, 2025-07-01, and 2025-07 were removed.
    Difference
    0.2%
    Check dated 2026-07-19T23:39:43.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3 on the page, reflecting a minor version bump. This does not modify study information, eligibility criteria, or any user-facing content.
    Difference
    0.1%
    Check dated 2026-07-05T04:58:12.000Z thumbnail image

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.